medigraphic.com
ISSN 1561-302X (Print)

2022, Number 1

<< Back Next >>

Rev cubana med 2022; 61 (1)

The epidemiology of pulmonary hypertension

Echarte MJC, Hechavarría PS, Alfonso RE

Language: Spanish
References: 30
Page: 1-12
PDF size: 352.73 Kb.


ABSTRACT

From current perspectives, pulmonary hypertension is considered a major health problem. The present work was carried out to identify the epidemiological characteristics and natural history of pulmonary hypertension in the international context and mainly in the Americas. Knowledge of the epidemiology of pulmonary hypertension has undergone a remarkable development with the results of the American, French, and Swiss registries, among others. Initial reports considered that the disease affected young patients (average age 36 years), being almost twice more frequent in women than in men (1.7:1) and with an incidence of 1-2 cases/1,000,000 inhabitants/ year and affects all age groups. Current estimates suggest a prevalence around 1% of the world population and increases to 10% in those over 65 years of age. Left atrial or left ventricular disease and pulmonary diseases are the most common cause of pulmonary hypertension. In Cuba there are no epidemiological data available on this entity. The programs that help their knowledge by the medical population must be reinforced and promote a single data registry.


REFERENCES

  1. Naval N. Epidemiología de la Hipertensión Pulmonar. Insuf Card. 2010[acceso: 23/03/2021];5(4):192-96. Disponible en: Disponible en: http://www.insuficienciacardiaca.org

  2. Rich S, Danzker DR, Ayres SM. Primary pulmonary hypertension: a National prospective study. Ann Intern Med 1987. 2012;107:216-23. DOI: https://doi.org/ 10.7326/0003-4819-107-2-216

  3. Alonzo GE, Barst RJ, Ayres SM. Survival in patients with primary pulmonary hypertension: Results of a National prospective study. Ann Intern Med 1991. 2012;115:343-49. DOI: https://doi.org/10.7326/0003-4819-115-5-343

  4. Sánchez Gómez JF, Tabernero E. La Hipertensión arterial Pulmonar. J Am Coll Cardiol. 2004[acceso: 23/03/2021];43:1s-90s. Disponible en: Disponible en: https://www.neumosur.net/files/publicaciones/ebook/44-HIPERTENSION-Neumologia-3_ed.pdf

  5. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Pulmonary arterial hypertension in France: Results from a National registry. Am J Respir Crit Care Med. 2006;173:1023-30. DOI: https://doi.org/10.1164/rccm.200510-1668OC

  6. Thenappan T, Shah SJ, Rich S. Gomberg-Maitland M. A USA- based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J. 2007;30:1103-10. DOI: https://doi.org/10.1183/09031936.00042107

  7. Mukeijee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, et al. Prevalence at outcome in systemic sclerosis associated pulmonary arterial hypertension. Application of a registry approach. Ann Rheum Dis. 2003;62;11:1088-93. DOI: https://doi.org/10.1136/ard.62.11.1088

  8. Bouzasa B, Gatzoulisb MA. Hipertensión arterial pulmonar en adultos con cardiopatía congénita. Rev Esp Cardiol. 2005;58(5):465-69. DOI: https://doi.org/10.1157/13074838

  9. McLaughlin VV, Presberg KW, Doyle RL, Abman SH, McCrory DC, Fortin T, et al. American College of Chest Physicians. Prognosis of pulmonary arterial hypertension. ACCP evidence-based clinical practice guideline. Chest. 2004;126:78S-92S. DOI. https://doi.org/10.1378/chest.126.1_suppl.78S

  10. Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med. 2002;166:314-22. DOI: https://doi.org/10.1164/rccm.2107027

  11. Chaouat A, Bugnet AS, Kadaoui N, Schott R, Enache I, Ducoloné A, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:189-94. DOI. https://doi.org/10.1164/rccm.200401-006OC

  12. Thabut G, Dauriat G, Stem JB, Logeart D, Lévy A, Marrash-Chahla R, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005;127:1531-36. DOI: https://doi.org/10.1378/chest.127.5.1531

  13. McGoon MD, Krichman A, Farber HW, Barst RJ, Raskob GE, Liou TG, et al. Design of the REVEAL Registry for US patients with pulmonar hypertension. Mayo Clin Proc. 2008;83(8):923-31. DOI: https://doi.org/10.4065/83.8.923

  14. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Pediatric and Congenital Cardiology (AEPC) International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67-119. DOI: http://dx.doi.org/10.1093/eurheartj/ehv317

  15. Naval N. Clasificación actual de la hipertensión pulmonar. Insuf. Card. 2011[acceso: 23/03/2021];6(1):30-38. Disponible en: Disponible en: http://www.insuficienciacardiaca.org

  16. Vanhoof JMM, Delcroix M, Vandervelde E, Denhaerynck K, Wuyts W, Beige C, et al. Emotional symptoms and quality of life in patients with pulmonary arterial hy pertension. J Heart Lung Transplant. 2014;33:800-08. DOI: https://doi.org/10.1016/j.healun.2014.04.003

  17. Morales BJ, Carmona RA, Rosas RM. Hipertensión arterial pulmonar, una entidad rara. Rev Invest Clin. 2014[acceso: 23/03/2021];66:65-78. Disponible en: Disponible en: http://www.medigraphic.com>pdfs.revinvcli

  18. Swiston J, Johnson R, Granton J. Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature. Respir Med. 2010;104:1588-1607. DOI: https://doi.org/10.1016/j.rmed.2010.08.003

  19. 19 . Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin W. Medical therapy for pulmonary arterial hypertension. Updated ACCP evidence-based clinical practice Guidelines. Chest. 2007;131:1917-28. DOI: https://doi.org/10.1378/chest.06-2674

  20. Barbera JA, Escribano P, Morales P, Gómez MA, Oribe M, Martínez A, et al. Standards of care in pulmonary hypertension. Rev Esp Cardiol. 2008;61(2):170-84. DOI: https://doi.org/10.1016/S1885-5857(08)60093-6

  21. Melero MJ. Estado actual de la hipertensión arterial pulmonar. Insuf Card. 2009[acceso: 23/03/2021];4(l):23-26. Disponible en: Disponible en: http://www.redalyc.org/articulo.oa?id=321927785005

  22. Hoeper MM, Marc Humbert M, Souza R, Idrees M, Kawut S, Sliwa-Hahnle K, et al. Perspectiva global de la Hipertensión Pulmonar. The Lancet Resp Med. 2016;4(4):306-322. DOI: https://doi.org/10.1016/S2213-2600(15)00543-3

  23. Lapa MS, Ferreira EV, Jardim C, Dos Santos Martin B, Sonoe J, Souza R. Clinical characteristics of pulmonary hypertension patients in two reference centres in the city of Sao Paulo. Rev Assoc Med Bras. 2006;52:139-43. DOI. https://doi.org/10.1590/s0104-42302006000300012

  24. Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):42-50. DOI: https://doi.org/10.1016/j.jacc.2013.10.032

  25. Moreira EM, Gall H, Leening MJ, Lahoose L, Loth DW, Krijdthe B, et al. Prevalence of pulmonary hypertension in the general population: the Rotterdam study. PLoS One. 2015;10:e0130072. DOI: https://doi.org/ 10.1371/journal.pone.0130072

  26. Galie N, Humbert M, Vachiery JL. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Pediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46:903-75. https://doi.org/10.1183/13993003.01032​-2015

  27. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28:523-32. DOI: https://doi.org/10.1183/09031936.06.00124605

  28. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2012 Incidence and Mortality Web-based Report. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute. 2015[acceso: 26/03/2021]. Disponible en: Disponible en: http://www.cdc.gov/uscs

  29. Hoeper MM, Madani MM, Nakanishi N, Meyer B, Cebotari S, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Lancet Respir Med. 2014;2(7):573-82. DOI. https://doi.org/10.1016/s2213-2600(14)70089

  30. Humbert M, Lau EM, Montani D, Jais X, Sitbon O, Simonneau G. Advances in therapeutic interventions for patients with pulmonary arterial hypertension. Circulation. 2014;130:2189-08. DOI: https://doi.org/10.1161/CIRCULATIONAHA.114.006974




2020     |     www.medigraphic.com